Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.10.0.1
Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:        
Research and development $ 1,580,511 $ 996,477 $ 4,178,294 $ 2,724,349
General and administrative 1,183,830 925,043 2,991,300 2,581,586
Total operating expenses 2,764,341 1,921,520 7,169,594 5,305,935
Loss from operations (2,764,341) (1,921,520) (7,169,594) (5,305,935)
Other income (expense):        
Interest income 9,066 3,004 15,794 6,771
Interest expense (2,142) (105,894) (3,643) (164,560)
Change in value of derivative liability   (42,918)   188,726
Local business tax (418) (588) (1,078) (2,988)
Other income   686   7,194
Total other income (expense), net 6,506 (145,710) 11,073 35,143
Loss before income taxes (2,757,835) (2,067,230) (7,158,521) (5,270,792)
Income tax benefit 0 0 0 0
Net loss (2,757,835) (2,067,230) (7,158,521) (5,270,792)
Net loss applicable to common shareholders $ (4,169,876) $ (2,067,230) $ (8,570,562) $ (5,270,792)
Basic and diluted net loss per share $ (0.35) $ (0.42) $ (1.12) $ (1.07)
Shares used to compute basic and diluted net loss per share 11,937,624 4,927,422 7,656,670 4,924,667
Series D Preferred Stock [Member]        
Other income (expense):        
Deemed dividend of Series D preferred stock $ (1,412,041)   $ (1,412,041)